C12Y 114/11031
Thebaine 6-o-demethylase
Official title: Thebaine 6-O-demethylase (1.14.11.31)
C12Y114/11031 (Thebaine 6-o-demethylase) appears on 3 US grants and 7 published applications in this corpus.
Search patents in C12Y- Granted patents
- 3
- Published applications
- 7
- Assignees
- 3
- Inventors
- 24
- Latest grant
- 23 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 1 | 0 |
| 2021 | 0 | 3 |
| 2022 | 0 | 1 |
| 2023 | 1 | 0 |
| 2024 | 0 | 1 |
| 2025 | 1 | 0 |
By publication year.
Recent patents
- Microbial cell with improved in vivo conversion of thebaine/oripavine23 Dec 2025US 12,503,706 B2River Stone Biotech, LLC
- Demethylation of reticuline and derivatives thereof with fungal cytochrome P45010 Oct 2023US 11,781,164 B2River Stone Biotech, LLC
- High thebaine poppy and methods of producing the same20 Oct 2020US 10,808,258 B2Api Labs Inc.
- Demethylation of Reticuline and Derivatives Thereof with Fungal Cytochrome P4509 May 2024US 2024/0150804 A1River Stone Biotech, LLC
- Methods of improving production of morphinan alkaloids and derivatives26 May 2022US 2022/0162656 A1
- Microbial cell with improved in vivo conversion of thebaine/oripavine9 Dec 2021US 2021/0380995 A1River Stone Biotech, LLC
- High thebaine poppy and methods of producing the same12 Aug 2021US 2021/0246460 A1Api Labs Inc.
- Demethylation of Reticuline and Derivatives Thereof with Fungal Cytochrome P45029 Jul 2021US 2021/0230655 A1River Stone Biotech, LLC
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.